Please login to the form below

Not currently logged in
Email:
Password:

Tocagen

This page shows the latest Tocagen news and features for those working in and with pharma, biotech and healthcare.

FDA grants Tocagen’s glioblastoma drug orphan status

FDA grants Tocagen’s glioblastoma drug orphan status

Harry Gruber, CEO of Tocagen, said: “There's an extraordinary need for new treatment options for patients with this devastating disease. ... This programme will be supported by companion diagnostic tests that Tocagen is working on in partnership with

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics